| 21-May-13 11:22AM | Idenix Pharmaceuticals' CEO Presents at UBS Global Healthcare Services Conference (Transcript) at Seeking Alpha |
| 15-May-13 08:37PM | Idenix Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) at Seeking Alpha |
| 13-May-13 12:35PM | Seth Klarman's Worst Performing Stock Picks Year-To-Date at Seeking Alpha |
| 08-May-13 04:05PM | Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences GlobeNewswire |
| 04-May-13 01:04PM | IDENIX PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 02-May-13 04:22PM | Gilead Misses Analysts Estimates on Sales of HIV Drugs at Bloomberg |
| 30-Apr-13 04:05PM | Idenix Pharmaceuticals Reports First Quarter 2013 Financial Results GlobeNewswire |
| 09:47AM | IDENIX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:47AM | IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 29-Apr-13 11:00AM | FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market: A Wall Street Transcript Interview with Brian Skorney, Senior Analyst at Robert W. Baird & Co. Wall Street Transcript |
| 24-Apr-13 08:01AM | InPlay: Idenix Pharma reports favorable resistance profile for IDX719, a potent, pan-genotypic HCV NS5A inhibitor, at EASL Meeting Briefing.com |
| 08:00AM | Idenix Reports Favorable Resistance Profile for IDX719, a Potent, Pan-Genotypic HCV NS5A Inhibitor, at EASL Meeting GlobeNewswire |
| 23-Apr-13 10:20PM | 3 Small Biotechs Top Hedge Funds Are Investing In at Motley Fool |
| 16-Apr-13 11:05AM | Achillion: Moving Beyond Sofosbuvir's Shadow at Seeking Alpha |
| 15-Apr-13 11:42AM | Should You Sell These Biotechnology Stocks at Motley Fool |
| 08-Apr-13 04:05PM | Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL) GlobeNewswire +7.04% |
| 29-Mar-13 10:45AM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 28-Mar-13 05:48PM | Setback for Idenix Pharma Zacks |
| 04:06PM | Gilead Hits Record High on Analysts View of Higher Sales at Bloomberg |
| 12:52PM | Gilead Hits Record High on Analysts View of Higher Sales at Bloomberg |
| 26-Mar-13 07:43PM | So Far, So Good for Gilead's Blockbuster at Motley Fool |
| 25-Mar-13 07:24PM | 2 Biotechs' Critical Patent Showdown at Motley Fool -19.78% |
| 03:11PM | [$$] Gilead Has an Edge on Indenix in Suit at Barrons.com |
| 02:07PM | Idenix Pharma shares sink on patent decision AP |
| 01:49PM | Idenix Pharmaceuticals' CEO Presents Idenix Provides Update on Patent Interference (Transcript) at Seeking Alpha |
| 01:32PM | Why Idenix Pharmaceuticals Shares Flopped at Motley Fool |
| 11:10AM | Idenix Pharma Drops After Faltering in Gilead Patent Dispute at Bloomberg |
| 09:06AM | Stock Futures Rise as Cyprus Deal Is Clinched at TheStreet |
| 09:02AM | Gilead prevails over Idenix, said to be 'senior party' in hep C patent ruling theflyonthewall.com |
| 07:54AM | Idenix Loses First Phase Of Patent Dispute With Gilead Sciences at TheStreet |
| 01:01AM | IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 22-Mar-13 04:17PM | InPlay: Idenix Pharma announces decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the first phase of the interference; Idenix was determined to be the 'junior party' Briefing.com |
| 04:12PM | Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference GlobeNewswire |
| 15-Mar-13 11:20AM | The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert at Seeking Alpha |
| 13-Mar-13 10:34PM | Idenix's Management Presents at Barclays Global Healthcare Conference (Transcript) at Seeking Alpha |
| 11-Mar-13 08:20AM | FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing Marketwire |
| 05-Mar-13 04:04PM | The Perfect Cure for Hepatitis C? at Motley Fool |
| 01-Mar-13 01:04PM | IDENIX PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 09:37AM | Idenix Reports In-Line 4Q Loss Zacks |
| 26-Feb-13 07:43PM | New Star Analyst Rankings for Idenix Pharmaceuticals, Inc. StarMine |
| 04:12PM | IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 04:05PM | Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire |
| 08:02AM | IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 25-Feb-13 04:40PM | Hepatitis C In Play for 2013? at Motley Fool |
| 04:33PM | IDENIX PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 04:05PM | Idenix Pharmaceuticals Reports Fourth Quarter and Year Ended 2012 Financial Results GlobeNewswire |
| 22-Feb-13 10:48AM | This Is One Incredible CEO at Motley Fool |
| 18-Feb-13 01:58PM | A Review Of Seth Klarman's Baupost Group's Q4 U.S. Equity Changes at Seeking Alpha |
| 17-Feb-13 08:26PM | Here's What Super-Investor Seth Klarman Has Been Buying at Motley Fool |
| 14-Feb-13 12:56PM | The Jury Is Still Out On The Risky NS5B Drugs at Seeking Alpha |
| 13-Feb-13 10:52AM | 5 Health Care Stocks Slumping in 2013 at Motley Fool |
| 12-Feb-13 09:19AM | New Stock Coverage: Get Your Kicks With Manchester United at Minyanville |
| 11-Feb-13 09:56PM | Fisking Ray Dirks On Medgenics And Shaming Seeking Alpha at TheStreet |
| 09:56PM | Fisking Ray Dirks on Medgenics and Shaming Seeking Alpha at TheStreet |
| 08:17PM | Coverage initiated on Idenix Pharma by Robert W. Baird Briefing.com |
| 05:50PM | Idenix Failure Clears The Way For Medgenics' Hepatitis C Blockbuster at Seeking Alpha |
| 12:17PM | Seth Klarman's Favorite Biotech Stock at TheStreet |
| 09-Feb-13 10:02AM | Has Gilead Sciences Become the Perfect Stock? at Motley Fool |
| 08-Feb-13 06:30AM | Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics at TheStreet |
| 07-Feb-13 04:38PM | Pipeline Setback for Idenix Zacks |
| 05-Feb-13 09:15PM | Guilty Until Proven Innocent at Motley Fool |
| 09:05PM | Idenix Pharmaceuticals' CEO Presents at Update on IDX184 and IDX19368 Development Programs Conference (Transcript) at Seeking Alpha |
| 04:05PM | Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire |
| 01:07PM | Idenix Nixes Development of 2 Hepatitis C Drugs at Motley Fool |
| 10:03AM | [video] Stock Futures Trade Higher on Upbeat Europe News at MarketWatch |
| 09:55AM | [video] Tuesday, Feb. 5, 2013: Three Stocks to Watch at MarketWatch |
| 09:11AM | Stocks to Watch: Yum Brands, Idenix Pharma, Opexa Therapeutics at The Wall Street Journal |
| 08:20AM | FDA Approved a Total of 39 New Drugs in 2012 -- Fifteen Year High Marketwire |
| 06:03AM | IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 04-Feb-13 06:35PM | Idenix drops development of 2 hepatitis C drugs AP |
| 05:29PM | Idenix Stops Development of Two Hepatitic C Treatments at Bloomberg |
| 04:42PM | Idenix Stops Development of Two Hepatitic C Treatments at Bloomberg |
| 04:08PM | InPlay: Idenix Pharma provides update on IDX184 and IDX19368 development programs: will not continue development of either drug (stock halted) Briefing.com |
| 04:05PM | Idenix Pharmaceuticals Provides Update on IDX184 and IDX19368 Development Programs GlobeNewswire |
| 03-Feb-13 06:34PM | Gilead Sciences Earnings: An Early Look at Motley Fool |
| 30-Jan-13 08:00PM | The Newest Hep-C Partnership at Motley Fool |
| 28-Jan-13 07:27PM | Partner = Buyout? Not So Fast. at Motley Fool |
| 07:24PM | 4 Healthcare Stock Stories Not to be Missed at Wall St. Cheat Sheet |
| 04:12PM | IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 01:25PM | Why Idenix Pharmaceuticals Shares Roared Higher at Motley Fool |
| 07:03AM | InPlay: Idenix Pharma announces collaboration with Janssen, unit of Johnson and Johnson (JNJ) to initiate Phase II All-oral combination studies including IDX719, Simeprevir Briefing.com |
| 07:00AM | Idenix Pharmaceuticals Announces Collaboration With Janssen to Initiate Phase II All-Oral Combination Studies Including IDX719, Simeprevir (TMC435) and TMC647055 for the Treatment of Hepatitis C Virus (HCV) GlobeNewswire |
| 21-Jan-13 11:21AM | Why You Should Sell Vertex at Seeking Alpha |
| 16-Jan-13 11:44AM | JPMorgan Healthcare Conference Highlights: Idenix Pharmaceuticals at Motley Fool |
| 15-Jan-13 05:04AM | 3 Highly Shorted Stocks Under $5 Being Snapped By Hedge Funds at Seeking Alpha |
| 11-Jan-13 09:00PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 08:20AM | Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013 Marketwire |
| 09-Jan-13 09:26PM | Idenix Pharmaceuticals CEO Presents at 31st Annual JPMorgan Healthcare Conference (Transcript) at Seeking Alpha -5.93% |
| 05:27PM | IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online |
| 05:26PM | Gilead commits to not using chimps in drug research at bizjournals.com |
| 04:19PM | Idenix May Drop Delayed Hepatitis C Drug for New Versions at Bloomberg |
| 03:19PM | Idenix May Drop Delayed Hepatits C Drug for New Versions at Bloomberg |
| 02:22PM | The Most Important New Drug of 2012 at Motley Fool |
| 01:38PM | Idenix Says FDA Needs More Time to Review Hold on Hepatitis C Drug at Minyanville |
| 12:47PM | Identix Falls on U.S. FDA Review of Hepatits C Drug Trial at Bloomberg |
| 04-Jan-13 06:02PM | Nasdaq stocks posting largest percentage increases AP +5.30% |
| 01:22PM | Nasdaq stocks posting largest percentage increases AP |
| 02-Jan-13 04:05PM | Idenix Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference GlobeNewswire |
| 29-Dec-12 08:59PM | 2012 Roundup -- HCV Treatments at Motley Fool |
| 02:05PM | Locking in Gains? Don't Make This Mistake at Motley Fool |
